| Neoplasm by Special Category investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 404show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 560 trials (129 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 560 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 389 trials (74 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 389 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 308 trials (36 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 308 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 251 trials (58 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 251 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 240 trials (53 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 240 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 228 trials (29 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 228 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 224 trials (31 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 224 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 222 trials (104 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 222 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 221 trials (47 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 221 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 212 trials (80 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 212 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 201 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 201 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 193 trials (48 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 193 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 189 trials (86 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 189 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 189 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 189 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 185 trials (33 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 185 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 175 trials (40 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 175 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 169 trials (44 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 169 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 164 trials (43 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 164 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 159 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 159 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 139 trials (31 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 139 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 139 trials (62 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 139 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 139 trials (22 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 139 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 129 trials (32 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 129 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 109 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 109 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 107 trials (27 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 107 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 104 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 104 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 101 trials (59 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 101 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 97 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 97 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 97 trials (33 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 97 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 96 trials (28 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 96 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 92 trials (20 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 92 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 89 trials (53 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 89 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 86 trials (24 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 86 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 80 trials (47 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 80 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 78 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 78 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 75 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 75 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 72 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 72 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 72 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 72 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 71 trials (34 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 62 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 62 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 61 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 61 trials (31 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 57 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 55 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 54 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 53 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 52 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 51 trials (25 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 49 trials (33 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 49 trials (27 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 49 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 48 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 48 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 47 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 47 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 47 trials (30 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 46 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 46 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 46 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 45 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 44 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 41 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 41 trials (16 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 41 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 39 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 38 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 36 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 36 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 36 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 35 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 33 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 33 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 32 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemtuzumab Ozogamicinadc 32 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 30 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 30 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 30 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 29 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 27 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 26 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 26 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 26 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 23 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 23 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 23 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 23 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 23 trials (17 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 22 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 22 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 21 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 21 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 21 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 20 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 20 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 20 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 19 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 19 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 19 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 19 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 18 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 18 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 18 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 18 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 18 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 18 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 17 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 16 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 16 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 15 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 14 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxyureasmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 14 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 14 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 14 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Quizartinibsmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 10 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tegafursmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinfluninesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Volasertibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 8 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Levoleucovorinsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX-4 Regimen 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Midostaurinsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitotanesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Revumenibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amsacrinesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CAPOX Regimen 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlorambucilsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 6 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Odronextamabmonoclonal antibody 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 6 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Special Category | 6 | Observed | clinicaltrials | graph → |